Assisting Social Security Disability Insurance Beneficiaries With Schizophrenia, Bipolar Disorder, or Major Depression in Returning to Work

被引:81
|
作者
Drake, Robert E. [1 ]
Frey, William
Bond, Gary R.
Goldman, Howard H.
Salkever, David
Miller, Alexander
Moore, Troy A.
Riley, Jarnee
Karakus, Mustafa
Milfort, Roline
机构
[1] Dartmouth Psychiat Res Ctr, Geisel Sch Med Dartmouth, Hanover, NH USA
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2013年 / 170卷 / 12期
关键词
INDIVIDUAL PLACEMENT; SUPPORTED EMPLOYMENT; CARE; PERFORMANCE; FIDELITY; ILLNESS; PEOPLE; SCALE; COSTS; MODEL;
D O I
10.1176/appi.ajp.2013.13020214
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: People with psychiatric impairments (primarily schizophrenia or a mood disorder) are the largest and fastest-growing group of Social Security Disability Insurance (SSDI) beneficiaries. The authors investigated whether evidence-based supported employment and mental health treatments can improve vocational and mental health recovery for this population. Method: Using a randomized controlled trial design, the authors tested a multifaceted intervention: team-based supported employment, systematic medication management, and other behavioral health services, along with elimination of barriers by providing complete health insurance coverage (with no out-of-pocket expenses) and suspending disability reviews. The control group received usual services. Paid employment was the primary outcome measure, and overall mental health and quality of life were secondary outcome measures. Results: Overall, 2,059 SSDI beneficiaries with schizophrenia, bipolar disorder, or depression in 23 cities participated in the 2-year intervention. The teams implemented the intervention package with acceptable fidelity. The intervention group experienced more paid employment (60.3% compared with 40.2%) and reported better mental health and quality of life than the control group. Conclusions: Implementation of the complex intervention in routine mental health treatment settings was feasible, and the intervention was effective in assisting individuals disabled by schizophrenia or depression to return to work and improve their mental health and quality of life.
引用
收藏
页码:1433 / 1441
页数:9
相关论文
共 50 条
  • [41] The expression of the transcription factor Oct-6 in schizophrenia, bipolar disorder and major depression
    Ubhi, K
    Price, JC
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 115S - 115S
  • [42] Age-at-first-admission of schizophrenia, bipolar disorder and major depression: Implications of heterogeneity
    Thomis, RJ
    Welham, JL
    Davies, G
    Chant, D
    Comes, S
    McGrath, JJ
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 61 - 62
  • [43] Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review
    Li, Xian-Bin
    Zheng, Wei
    Ning, Yu-Ping
    Cai, Dong-Bin
    Yang, Xin-Hu
    Ungvari, Gabor S.
    Ng, Chee H.
    Wang, Chuan-Yue
    Xiang, Yu-Tao
    PHARMACOPSYCHIATRY, 2018, 51 (03) : 100 - 104
  • [44] Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs
    S L Eastwood
    P J Harrison
    Molecular Psychiatry, 2000, 5 : 425 - 432
  • [45] Genetic Risk Loading for Schizophrenia, Bipolar Disorder, and Major Depression and Hippocampal Subregion Volumes
    Tuominen, Lauri
    Vettermann, Richard
    Ge, Tian
    Ho, Newfei
    Holmes, Avram
    Sabuncu, Mert
    Smoller, Jordan
    Lee, Phil
    Buckner, Randy
    Roffman, Joshua
    Holt, Daphne
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S223 - S223
  • [46] Adolescent residential mobility, genetic liability and risk of schizophrenia, bipolar disorder and major depression
    Paksarian, Diana
    Trabjerg, Betina B.
    Merikangas, Kathleen R.
    Mors, Ole
    Borglum, Anders D.
    Hougaard, David M.
    Nordentoft, Merete
    Werge, Thomas
    Pedersen, Carsten B.
    Mortensen, Preben B.
    Agerbo, Esben
    Horsdal, Henriette Thisted
    BRITISH JOURNAL OF PSYCHIATRY, 2020, 217 (01) : 390 - 396
  • [47] Phosphodiesterase signaling system is disrupted in the cerebella of subjects with schizophrenia, bipolar disorder, and major depression
    Fatemi, S. Hossein
    Folsom, Timothy D.
    Reutiman, Teri J.
    Vazquez, Gabriela
    SCHIZOPHRENIA RESEARCH, 2010, 119 (1-3) : 266 - 267
  • [48] SOCIAL SECURITY DISABILITY INSURANCE: ESSENTIAL PROTECTION WHEN WORK INCAPACITY STRIKES RESPONSE
    Burkhauser, Richard V.
    Daly, Mary C.
    JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 2012, 31 (02) : 469 - 471
  • [49] Epidemiology of first episode bipolar disorder: Systematic comparison to major depression with psychotic features, schizoaffective disorder and schizophrenia
    Waddington, John L.
    BIPOLAR DISORDERS, 2006, 8 : 18 - 18
  • [50] Advances in the knowledge and therapeutics of schizophrenia, major depression disorder, and bipolar disorder from human brain organoid research
    Villanueva, Rosa
    FRONTIERS IN PSYCHIATRY, 2023, 14